A novel selective 11b-hydroxysteroid dehydrogenase type 1 inhibitor prevents human adipogenesis



302 I J BUJALSKA and others . 11b-HSD1 is essential for human adipogenesis

Day О — oil red O staining


Day 21 — oil red O staining


DNA NegCtr 18S 11β-HSDI GRa H6PDH PPARgI PPARg2 GLUT4 G3PD FABP4
ladder

Figure 3 Oil red O staining in (A) confluent Chub-S7 cells (day 0) and (B) differentiated Chub-S7 (day 21). RT-PCR analysis (30 cycles) of
nine gene expressions in (C) confluent Chub-S7 cells and (D) in differentiated Chub-S7 cells.


DNA NegCtr 18S 11β-HSDI GRa H6PDH PPARgI PPARg2 GLUT4 G3PD FABP4
ladder


Human subcutaneous s—v cells differentiation

Human subcutaneous s—v cells differentiated with ECPF-
877423 had significantly lower 11
b-HSD1 oxo-reductase
activity compared with cells differentiated with E at any time
point studied (day 6: 154
G8 vs 5387G182; day 9: 128G1 vs
5489
G230; day 14: 174G18 vs 4041G106; day 20: 409G27
vs 10443
G78; day 22: 330G7 vs 11218G193 pg/ml per 24 h,
mean
GS.D., P!0.001, nZ3, EK or ECPF-877423 treated
respectively (
Fig. 7A)). Lipid content in cells differentiated
with E and PF-877423 was significantly lower than in cells
differentiated with E only and similar to undifferentiated cells
(day 16, 0
.25G0.03 vs 0.20G0.01; day 20, 0.3G0.02 vs
0
.20G0.01; day 22, 0.27G0.01 vs 0.19G0.01; OD (500/
660 nm); mean
GS.D., P!0.01, nZ3, EK or ECPF-877423
treated respectively;
Fig. 7B).

Discussion

Numerous studies (Hauner et al. 1989, Gregoire et al. 1991, Wolf
1999
), including our own (Bujalska et al. 1999, 2002b), have


Figure 4 (A) 11b-HSD1 oxo-reductase activity (cortisone to cortisol conversion); nil on day 0 to 0.4G0.2 on day 3,
5
.3G0.7 on day 5, 8.4G0.14 on day 7, 10.5G1.9 on day 9 and 5.9G1.9 on day 16, pmol/mg per h, meanGS.D. versus
previous time point, n
Z7 and mRNA levels measured by real-time PCR of (B) 11b-HSD1 (2.9-fold increase on day 5,
3
.6-fold on day 7, 3.4-fold on day 9 and 38.1-fold on day 16 when compared with day 3). (C) H6PDH increased 2.9-
fold on day 3, 3
.5-fold on day 5, 3.7-fold on day 7, 3.4-fold on day 9 and 0.6-fold on day 16 versus day 0 and (D) GRa
(no significant change) across Chub-S7 differentiation, n
Z4. P values: **P!0.01, ***P!0.001.


Journal of Endocrinology (2008) 197, 297-307

www.endocrinology-journals.org




More intriguing information

1. The name is absent
2. Effects of red light and loud noise on the rate at which monkeys sample the sensory environment
3. The name is absent
4. Bidding for Envy-Freeness: A Procedural Approach to n-Player Fair Division Problems
5. Multi-Agent System Interaction in Integrated SCM
6. LAND-USE EVALUATION OF KOCAELI UNIVERSITY MAIN CAMPUS AREA
7. FUTURE TRADE RESEARCH AREAS THAT MATTER TO DEVELOPING COUNTRY POLICYMAKERS
8. Monetary Policy News and Exchange Rate Responses: Do Only Surprises Matter?
9. Strategic Investment and Market Integration
10. The name is absent
11. 101 Proposals to reform the Stability and Growth Pact. Why so many? A Survey
12. The name is absent
13. The name is absent
14. DURABLE CONSUMPTION AS A STATUS GOOD: A STUDY OF NEOCLASSICAL CASES
15. Draft of paper published in:
16. The name is absent
17. Sectoral Energy- and Labour-Productivity Convergence
18. Manufacturing Earnings and Cycles: New Evidence
19. A Pure Test for the Elasticity of Yield Spreads
20. Analyzing the Agricultural Trade Impacts of the Canada-Chile Free Trade Agreement